![]() |
|
|
Forward to a colleague |
||
Access Full Stories Bristol-Myers Squibb (BMS) has finally detailed its plans to trim the fat and save cash, months after first revealing that big changes would be on the cards... Read Morphosys to exit fee-for-service upon Novartis deal Morphosys has landed in the money after scoring a lucrative 10 year antibody development deal with Novartis and as a result, will now place all its eggs in one basket and cut ties with its fee-for-service customers... Read Microfluidics promises a bright future for cell-based assays UK researchers have published results that show that microfluidic devices can provide robust quantitative pharmacological information from low numbers of single cells... Read Separating mixtures in an NMR machine Canadian researchers have devised a method of extracting the complete proton NMR (nuclear magnetic resonance) spectra for a component of a mixture without the need for physical separation... Read Drugs moving into the clinic: 38 The latest in a series of periodic roundups of drugs that have moved from preclinical research into clinical testing via the announcement of a Phase I trial or an application for a trial to industry regulators... Read |
|||||||||||||||||
All News Headlines for: December | November | October |
|||||||||||||||||
CappAero pipettes - ultimate accuracy and intelligent design The cool transparent handle and dash of vibrant colour on the barrel ensures the ColorLine series will be a welcome addition to any laboratory. The distinctive colour of each pipette permits you to quickly identify the volume range of any pipette at a glance... Click Here | |||||||||||||||||
|
Related Industry News Abbott cuts jobs, closes plant in Ireland Abbott is to shut its doors on its Galway, Ireland, facility - taking 500 jobs with it - as the market moves into murky waters over the future of vascular stents... Read Eisai selects Singapore as Asia trials hub Eisai is planning to step up its clinical research presence in Asia and has chosen Singapore as a hub from which to coordinate its research activities... Read Arius and Avid team up Arius Research and Avid Bioservices have joined forces in the manufacturing and development of an anticancer antibody... Read Combo products need guidelines The combination products market is zooming ahead, requiring the need to address regulatory challenges, an author of a white paper says... Read
|
|||||||||||||||||
|
|||||
Forward to a colleague |
|||||
To continue to receive this newsletter in your inbox, please add newsletter@DrugResearcher.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||